Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
about
Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRIPancreatic cancer and FOLFIRINOX: a new era and new questions.Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal AdenocarcinomaComplete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and reviewOutcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer.Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.Transport properties of pancreatic cancer describe gemcitabine delivery and responseComplete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.Surgical management of pancreatic neoplasms: what's new?Concomitant major vessel resection in pancreatic adenocarcinoma.The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study.Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.Neoadjuvant therapy for pancreatic cancer: an ongoing debate.Response assessment in pancreatic ductal adenocarcinoma: role of imaging.Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
P2860
Q33750803-3291F3CD-440C-4CD6-8CB3-C0CE7B3C9043Q34493969-95A50BF5-E8F2-4DCD-93E3-8EC1E92A5BD0Q35680690-B996C146-DB0D-42FC-A2A6-A41C30A82DA6Q35755386-FDB2E978-9431-4DD8-9C81-AB3A37739FF6Q35972678-A348ADF7-1DD4-442E-B32C-73CC2AB6EA9EQ36159880-734162B9-A607-46B7-8CE1-BC1561461691Q37277436-27B9B5F2-119C-430B-82E1-276F09B1EDA0Q37333036-95D6C3EB-3761-4B5A-AC4B-E80A646081D3Q37624171-F0909B13-257D-46A9-9016-CA584D3E5891Q37679971-779D37AD-88FA-4375-9EFD-3A112CE9E22EQ37714700-E79D9609-2741-489C-8C6C-8F8780F370FAQ38234195-ECDCC113-CE56-4E14-992A-BA31BA60818DQ38396188-811B8BC1-48BF-456F-8B3B-A8D0A8D5C020Q38750088-1A8F1F66-4351-4101-A65D-FEF6161FA621Q39342560-4F3ACAB2-D2EB-4C0C-93F3-88A25C6C8CC8Q39430849-73C7BDBC-7522-4B42-8549-EF04566F43FAQ40160341-71A3A1C4-391D-4912-A634-211A3A2641F8Q40580320-735A8483-7600-4D98-83EC-41422C0C8EF5Q41826893-C070DF55-6B5E-44A2-A162-EAAA6183FC56Q48113453-A5A7796D-5B65-43EC-9DD5-E74AE8046C16Q51772050-4EB9EA77-2ABD-43C1-ADD7-3807C071DA65
P2860
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Pathologic complete response t ...... iated with a better prognosis.
@en
Pathologic complete response t ...... iated with a better prognosis.
@nl
type
label
Pathologic complete response t ...... iated with a better prognosis.
@en
Pathologic complete response t ...... iated with a better prognosis.
@nl
prefLabel
Pathologic complete response t ...... iated with a better prognosis.
@en
Pathologic complete response t ...... iated with a better prognosis.
@nl
P2093
P2860
P1476
Pathologic complete response t ...... iated with a better prognosis.
@en
P2093
Aparna Balachandran
Asif Rashid
Gauri R Varadhachary
Henry F Gomez
Huamin Wang
James L Abbruzzese
Jason B Fleming
Jeffrey E Lee
Matthew H Katz
P2860
P356
10.1016/J.ANNDIAGPATH.2011.08.005
P577
2011-11-03T00:00:00Z